Clinical evaluation of negative symptoms in schizophrenia

European Psychiatry

Volumn 22, Issue 6, 2007, Pages 380-386

  Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Algorithm; Diagnosis; Persistent negative symptoms; Schizophrenia

Indexed keywords

AFFECT; ALGORITHM; ANHEDONIA; ANTISOCIAL BEHAVIOR; APATHY; ARTICLE; ATTENTION DISTURBANCE; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; MOTOR RETARDATION; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RATING SCALE; SCHIZOPHRENIA; SPEECH DISORDER;

ALGORITHMS; COGNITION DISORDERS; DELUSIONS; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; HALLUCINATIONS; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 34548548362     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.03.010     Document Type: Article

References (37)

1. Alphs L., Daniel D.G., Velligan D., Bartko J., Panagides J., and Davis J. Training for assessment of negative symptoms of schizophrenia across languages and cultures utilizing the Negative Symptom Assessment Scale. Neuropsychopharmacology 30 Suppl. 1 (2005) S113
2. Alphs L.D., Summerfelt A., Lann H., and Muller R.J. The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia. Psychopharmacol Bull 25 2 (1989) 159-163
3. Amador X.F., Kirkpatrick B., Buchanan R.W., Carpenter W.T., Marcinko L., and Yale S.A. Stability of the diagnosis of deficit syndrome in schizophrenia. Am J Psychiatry 156 4 (1999 Apr) 637-639
4. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) (1981), University of Iowa, Iowa City, IA
5. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 39 7 (1982) 784-788
6. Andreasen N.C., and Olsen S. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 39 7 (1982) 789-794
7. Bell M.D., and Mishara A.L. Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophr Res 81 1 (2006 Jan 1) 17-27
8. Berk M., Ichim C., and Brook S. Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Int Clin Psychopharmacol 16 2 (2001 Mar) 87-92
9. Bottlender R., Sato T., Groll C., Jager M., Kunze I., and Moller H.J. Negative symptoms in depressed and schizophrenic patients: how do they differ?. J Clin Psychiatry 64 8 (2003) 954-958
10. Bottlender R., Wegner U., Wittmann J., Strauss A., and Moller H.J. Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study. Eur Arch Psychiatry Clin Neurosci 249 Suppl. 4 (1999) 27-36
11. Bow-Thomas C.C., Velligan D.I., Miller A.L., and Olsen J. Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatry Res 86 2 (1999) 131-142
12. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull (2006 Nov 10)
13. Carpenter Jr. W.T., Heinrichs D.W., and Wagman A.M. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145 5 (1988) 578-583
14. Csernansky J.G. Treatment of schizophrenia: preventing the progression of disease. Psychiatr Clin North Am 26 2 (2003 Jun) 367-379
15. Delamillieure P., Ochoa-Torres D., Vasse T., Brazo P., Gourevitch R., Langlois S., et al. The subjective quality of life in deficit and nondeficit schizophrenic patients. Eur Psychiatry 20 4 (2005 Jun) 346-348
16. Fitzgerald P.B., de Castella A.R., Filia K., Collins J., Brewer K., Williams C.L., et al. A longitudinal study of patient- and observer-rated quality of life in schizophrenia. Psychiatry Res 119 1-2 (2003) 55-62
17. Fitzgerald P.B., Williams C.L., Corteling N., Filia S.L., Brewer K., Adams A., et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 103 5 (2001) 387-392
18. Gorecka J.E., and Czernikiewicz A. [The relationship between quality of life of schizophrenic patients and clinical parameters of psychosis]. Wiad Lek 57 9-10 (2004) 408-412
19. Harvey P.D., Koren D., Reichenberg A., and Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr Bull 32 2 (2006 Apr) 250-258
20. Iancu I., Poreh A., Lehman B., Shamir E., and Kotler M. The Positive and Negative Symptoms Questionnaire: a self-report scale in schizophrenia. Compr Psychiatry 46 1 (2005) 61-66
21. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 2 (1987) 261-276
22. Keefe R.S., Bilder R.M., Harvey P.D., Davis S.M., Palmer B.W., Gold J.M., et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 31 9 (2006 Sep) 2033-2046
23. Kirkpatrick B., Buchanan R.W., McKenney P.D., Alphs L.D., and Carpenter Jr. W.T. The Schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30 2 (1989 Nov) 119-123
24. Kirkpatrick B., Fenton W.S., Carpenter Jr. W.T., and Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 32 2 (2006 Apr) 214-219
25. Lublin H., Eberhard J., and Levander S. Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics. Int Clin Psychopharmacol 20 4 (2005) 183-198
26. Malla A., and Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull 31 3 (2005 Jul) 650-671
27. Moller H.J. Atypical neuroleptics: a new approach in the treatment of negative symptoms. Eur Arch Psychiatry Clin Neurosci 249 Suppl. 4 (1999) 99-107
28. Moller H.J. Management of the negative symptoms of schizophrenia: new treatment options. CNS Drugs 17 11 (2003) 793-823
29. Moller H.J. Non-neuroleptic approaches to treating negative symptoms in schizophrenia. Eur Arch Psychiatry Clin Neurosci 254 2 (2004 Apr) 108-116
30. Moller H.J., Bottlender R., Wegner U., Wittmann J., and Strauss A. Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand Suppl 407 (2000) 54-57
31. Perkins D.O., Gu H., Boteva K., and Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162 10 (2005 Oct) 1785-1804
32. Rudnick A., and Kravetz S. The relation of social support-seeking to quality of life in schizophrenia. J Nerv Ment Dis 189 4 (2001) 258-262
33. Svirskis T., Korkeila J., Heinimaa M., Huttunen J., Ilonen T., Ristkari T., et al. Quality of life and functioning ability in subjects vulnerable to psychosis. Compr Psychiatry 48 2 (2007 Mar-Apr) 155-160
34. Tremeau F. A review of emotion deficits in schizophrenia. Dialogues Clin Neurosci 8 1 (2006) 59-70
35. Velligan DI, Wang M, Haig G, Lancaster S, Taylor TN, Alphs L. Association between changes in negative symptoms and functional outcome measures in a stable schizophrenic population. American Psychiatric Association 159th Annual Meeting, 2006 May 20-25, Toronto, Ontario, Canada; 2006.
36. Winograd-Gurvich C., Fitzgerald P.B., Georgiou-Karistianis N., Bradshaw J.L., and White O.B. Negative symptoms: a review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull 70 4-6 (2006 Oct 16) 312-321
37. Yon V., Loas G., and Brien D. Subjective experiences and the psychopathological dimensions in schizophrenia. Psychiatry Res 137 1-2 (2005 Nov 15) 93-102